
DR. VESILE SCHNEIDER
-
Since 2012Branch as an internist in her own
Family doctor’s practice in Friedrichshafen -
Since 2010Specialist in internal medicine
-
2009-2010Cardiology, Lahr Clinic
-
2006-2008Oncology, Sanafontis Tumor Clinic, Freiburg
-
2000-2002Internal Medicine, Herbolzheim City Hospital
-
1999-2000Research Fellowship, Department Gastroenterology, Mayo Clinic, Rochester/MN USA
-
1992-1999Studied human medicine at the University of Witten/Herdecke
Promotion: Refinement of the extracellular structure of the CCK-A-Receptor -
1991Abitur at the Gutenberg-Gymnasium in Mainz
Let the visitor know more about your company and your team
This is placeholder text which will be replaced by your content. Lorem ipsum amet elit morbi dolor tortor. Vivamus eget mollis nostra ullam corper. Pharetra torquent auctor metus felis nibh velit. Natoque tellus semper taciti nostra. Semper pharetra montes habitant congue integer primis vivamus aptent.
Pretium lorem primis lectus donec tortor fusce morbi risus curae. Dignissim lacus massa mauris enim mattis magnis senectus montes mollis taciti accumsan semper blandit nibh aliquam metus morbi cras magna vivamus per risus. Dapibus imperdiet praesent magnis congue gravida magna netus inceptos iaculis.
“This is testimonial placeholder text which will be replaced by your content. Lorem ipsum amet elit morbi dolor tortor. Vivamus eget mollis nostra ullam corper. Pharetra torquent auctor metus felis nibh velit. Semper pharetra montes habitant congue integer magnis nulla.”

Customer Name
Business Name


Story
Tell your story and the journey you have made
-
DateEvent TitleProvide a short summary of the event. Lorem ipsum dolor sit amet, consectetur adipiscing elit.
-
DateEvent TitleProvide a short summary of the event. Lorem ipsum dolor sit amet, consectetur adipiscing elit.
-
DateEvent TitleProvide a short summary of the event. Lorem ipsum dolor sit amet, consectetur adipiscing elit.
-
DateEvent TitleProvide a short summary of the event. Lorem ipsum dolor sit amet, consectetur adipiscing elit.
Vision
Shout out your companies vision to attract new talent, partners & investors
Feature your service promises and guarantees
This sub headline is a text block global style that is larger and bolder.
Promise headline
This is placeholder text which will be replaced by your content. Lorem ipsum amet elit morbi dolor tortor. Vivamus eget mollis nostra ullam corper. Pharetra torquent auctor metus felis nibh velit natoque tellus semper taciti nostra.
Promise headline
This is placeholder text which will be replaced by your content. Lorem ipsum amet elit morbi dolor tortor. Vivamus eget mollis nostra ullam corper. Pharetra torquent auctor metus felis nibh velit natoque tellus semper taciti nostra.
Promise headline
This is placeholder text which will be replaced by your content. Lorem ipsum amet elit morbi dolor tortor. Vivamus eget mollis nostra ullam corper. Pharetra torquent auctor metus felis nibh velit natoque tellus semper taciti nostra.
Promise headline
This is placeholder text which will be replaced by your content. Lorem ipsum amet elit morbi dolor tortor. Vivamus eget mollis nostra ullam corper. Pharetra torquent auctor metus felis nibh velit natoque tellus semper taciti nostra.
Assure the visitor you can help solve their problem and invite them to contact you
This is placeholder text which will be replaced by your content. Pretium lorem primis lectus donec tortor fusce morbi risus curae. Dignissim lacus massa mauris enim mattis magnis senectus montes mollis taciti semper blandit nibh aliquam metus morbi.
Schedule an AppointmentNeed Emergency Service?
Call (888) 555-5555
Publications
Schneider V, Rischke HC, Drevs J,
Chapter “Angiogenesis” in: The Impact of Tumor Biology on Cancer Treatment and Multidisciplinary Strategies (Medical Radiology / Radiation Oncology) by M. Molls, AJ Giaccia, Carsten Nieder, and MS Anscher
Springer, Berlin (3. March 2009)
T. Trarbach, J. Drevs, D. Strumberg, TC Gauler, V. Schneider, WE Eberhardt, M. Marotti, TA Puchalski, AJ Swaisland
A phase I, open-label, multicenter study of cediranib and AZD0530 in patients with advanced solid tumors.
J Clin Oncol 26:2008 (May 20 suppl; abstr 3592)
Schneider V
Imaging in Tumor angiogenesis (German), chapter in “Tumor angiogenesis, basis and therapeutic approaches.”
Uni-Med Bremen (2007)
Schneider V, Drevs J,
The use of vascular biomarkers and imaging studies in the early clinical development of antitumor agents targeting angiogenesis.
J Intern Med. 2006 Dec;260(6):517-29. Review.
Ding XQ, Dolu V, Hadac EM, Schuetz M, Miller LJ
Disulfide bond structure and accessibility of cysteines in the ectodomain of the cholecystokinin receptor: specific mono-reactive receptor constructs examine charge-sensitivity of loop regions.
Receptors Channels. 2003;9(2):83-91.
Ding XQ, Dolu V, Hadac EM, Holicky EL, Pinon DI, Lybrand TP, Miller LJ.
Refinement of the structure of the ligand-occupied cholecystokinin receptor using a photolabile amino-terminal sample.
J Biol Chem. 2001 Feb 9;276(6):4236-44. Epub 2000 Oct 24.
Holtmann MH, Ganguli S, Hadac EM, Dolu V, Miller LJ
Multiple extracellular loop domains contribute critical determinants for agonist binding and activation of the secretin receptor.
J Biol Chem. 1996 Jun 21;271(25):14944-9.